Zenith Pharmaceuticals Limited - Dormant company accounts 17.1

Report of the Directors and

Unaudited Financial Statements for the Period 1 June 2016 to 31 December 2016

for

Zenith Pharmaceuticals Limited

Page

Company Information

1

Report of the Directors

2

Balance Sheet

3

Income Statement

4

Notes to the Financial Statements

5

Chartered Accountants' Report

6

DIRECTORS:

S Tate

Mrs M J Tate

R Warriner

SECRETARY:

Mrs M J Tate

REGISTERED OFFICE:

Jubilee House

3 The Drive

Great Warley

Brentwood

Essex

CM13 3FR

BUSINESS ADDRESS:

New Abbey Court

51-53 Stert Street

Abingdon

Oxfordshire

OX14 3JF

REGISTERED NUMBER:

04510052 (England and Wales)

ACCOUNTANTS:

Neville & Stocker

Jubilee House

3 The Drive

Great Warley

Brentwood

Essex

CM13 3FR

The directors present their report with the financial statements of the company for the period 1 June 2016 to 31 December 2016.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 June 2016 to the date of this report.

S Tate

Mrs M J Tate

R Warriner

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small

companies.

ON BEHALF OF THE BOARD:

S Tate - Director

30 August 2017

CURRENT ASSETS

Cash at bank

17,070

17,120

CREDITORS

Amounts falling due within one year

3

13,139

13,189

NET CURRENT ASSETS

3,931

TOTAL ASSETS LESS CURRENT
LIABILITIES

3,931

CAPITAL AND RESERVES

Called up share capital

112

Retained earnings

3,819

SHAREHOLDERS' FUNDS

3,931

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the period ended 31 December 2016.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 30 August 2017 and were signed on its behalf by:

S Tate - Director

During the financial year and the preceding financial year the company has not traded and has received no income and incurred no expenditure. Consequently, during those periods the company has made neither a profit nor a loss.

1.	STATUTORY INFORMATION

Zenith Pharmaceuticals Limited is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

3.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2016

£

Other creditors

13,139

13,189

4.	RELATED PARTY DISCLOSURES

At the period end Zenith Pharmaceuticals Limited owed £13,139 (31 May 2016: £13,189) to Wallace

Manufacturing Chemists Limited.

The ultimate parent company of Wallace Manufacturing Chemists Limited is Alinter Limited which is controlled

by Mrs M J Tate. Mrs M J Tate is a director of all three companies.

5.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mrs M J Tate.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements of Zenith Pharmaceuticals Limited for the period ended 31 December 2016 which comprise the

Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and

explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Zenith Pharmaceuticals Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Zenith Pharmaceuticals Limited and state those matters that we have agreed to state to the Board of Directors of Zenith Pharmaceuticals Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Zenith Pharmaceuticals Limited Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Zenith Pharmaceuticals Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Zenith Pharmaceuticals Limited. You consider that Zenith Pharmaceuticals Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Zenith Pharmaceuticals Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Neville & Stocker

Jubilee House

3 The Drive

Great Warley

Brentwood

Essex

CM13 3FR

5 September 2017